Optomed Oyj Past Earnings Performance
Past criteria checks 0/6
Optomed Oyj's earnings have been declining at an average annual rate of -15.3%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 0.9% per year.
Key information
-15.3%
Earnings growth rate
-2.6%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 0.9% |
Return on equity | -22.8% |
Net Margin | -29.3% |
Next Earnings Update | 08 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Optomed Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 15 | -4 | 9 | 0 |
31 Dec 23 | 15 | -4 | 9 | 0 |
30 Sep 23 | 15 | -4 | 9 | 0 |
30 Jun 23 | 15 | -5 | 10 | 0 |
31 Mar 23 | 15 | -5 | 10 | 0 |
31 Dec 22 | 15 | -5 | 10 | 0 |
30 Sep 22 | 14 | -6 | 10 | 0 |
30 Jun 22 | 14 | -5 | 9 | 0 |
31 Mar 22 | 14 | -5 | 9 | 0 |
31 Dec 21 | 15 | -4 | 9 | 0 |
30 Sep 21 | 15 | -3 | 9 | 0 |
30 Jun 21 | 15 | -2 | 8 | 0 |
31 Mar 21 | 14 | -3 | 8 | 0 |
31 Dec 20 | 13 | -3 | 8 | 0 |
30 Sep 20 | 13 | -3 | 8 | 0 |
30 Jun 20 | 13 | -4 | 8 | 0 |
31 Mar 20 | 15 | -4 | 8 | 0 |
31 Dec 19 | 15 | -3 | 8 | 0 |
30 Sep 19 | 16 | -2 | 7 | 0 |
31 Dec 18 | 14 | -1 | 6 | 0 |
31 Dec 17 | 7 | -3 | 4 | 0 |
31 Dec 16 | 7 | -3 | 4 | 0 |
Quality Earnings: 36U0 is currently unprofitable.
Growing Profit Margin: 36U0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 36U0 is unprofitable, and losses have increased over the past 5 years at a rate of 15.3% per year.
Accelerating Growth: Unable to compare 36U0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 36U0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).
Return on Equity
High ROE: 36U0 has a negative Return on Equity (-22.75%), as it is currently unprofitable.